Treatment
IBI362 clinical trials
We’re tracking 5 recruiting studies that include IBI362, each written for real people, not researchers, below.
Recruiting studies
- NCT07255209RecruitingPhase 3
A study of IBI362 for Chinese teens with obesity or overweight
This trial tests a new medicine, IBI362, to help Chinese adolescents lose weight. It may be an option if you are 12 to 17 years old and have obesity or overweight with a related health condition.
Hangzhou, ZhejiangAges 12–18 - NCT06937749RecruitingPhase 2
Study of IBI362 for liver scarring from MASH
This trial tests an investigational drug called IBI362 for people with MASH, a type of fatty liver disease that has caused liver scarring (stage F2 or F3). The study aims to see if the drug can improve the liver's health.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06862908RecruitingPhase 2
Study of IBI362 for heart failure with obesity
This study tests a new medicine called IBI362 for people with heart failure and obesity. The medicine may help improve symptoms and quality of life. You must have a specific type of heart failure (HFpEF or HFmrEF) and a BMI of 28 or higher.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06931028RecruitingPhase 3
Study of IBI362 for sleep apnea with obesity
This study tests an investigational medication (IBI362) to see if it can improve sleep apnea in people with obesity. You might qualify if you have moderate to severe sleep apnea and a BMI of 28 or higher, whether or not you currently use a CPAP machine.
BeijingAges 18 years+ - NCT07469800RecruitingPhase 3
IBI362 for high blood pressure in overweight adults
This study tests an injectable medicine (IBI362) to see if it helps lower blood pressure in people who are overweight or have obesity. You may be eligible if you have high blood pressure but are not currently taking medication for it, and you do not have diabetes or major heart problems.
Shanghai, Shanghai MunicipalityAges 18 years+
What IBI362 is being studied for
Conditions with recruiting IBI362 studies.
Common questions
- Are there clinical trials studying IBI362?
- Yes. Clin2 currently lists 5 recruiting studies that include IBI362, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a IBI362 trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is IBI362 an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether IBI362 or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.